Sunshine Biopharma Inc. (SBFMW)
0.22
-0.02 (-10.20%)
At close: Mar 24, 2025, 1:49 PM
-10.20% (1D)
| Bid | 0.16 |
| Market Cap | 5.54M |
| Revenue (ttm) | 785.61M |
| Net Income (ttm) | -100.73M |
| EPS (ttm) | -2.214 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.28 |
| Volume | 2,410 |
| Avg. Volume (20D) | 19,764.986 |
| Open | 0.21 |
| Previous Close | 0.24 |
| Day's Range | 0.21 - 0.30 |
| 52-Week Range | 0.21 - 0.30 |
| Beta | -1.48 |
About SBFMW
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast c...
Full Company Profile